Kolmar BioTech, Inc. (KOSDAQ:215380)
South Korea · Delayed Price · Currency is KRW 2,360.00
0.00 (0.00%)
At close: Aug 11, 2026
Kolmar BioTech Market Cap
Kolmar BioTech has a market cap or net worth of 39.72 billion as of August 11, 2026. Its market cap has increased by 43.64% in one year.
Market Cap
39.72B
Enterprise Value
55.43B
Revenue
40.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,360.00
ChartMarket Cap Chart
Since April 27, 2017, Kolmar BioTech's market cap has decreased from 51.29B to 39.72B, a decrease of -22.56%. That is a compound annual growth rate of -2.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 39.72B | 34.01% |
| Dec 30, 2025 | 29.64B | 3.59% |
| Dec 30, 2024 | 28.61B | 5.65% |
| Dec 28, 2023 | 27.08B | -29.98% |
| Dec 29, 2022 | 38.68B | -52.23% |
| Dec 30, 2021 | 80.97B | -29.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 231.38B |
| DreamCIS | 85.49B |
| P&K Skin Research Center | 52.65B |
| HLB bioStep | 38.56B |
| SLS BIO | 26.89B |
| DT&CRO CO. | 23.51B |
| C&R Research | 22.14B |
| Curachem | 12.65B |